Matinas BioPharma
MTNB
MTNB
47 hedge funds and large institutions have $3.37M invested in Matinas BioPharma in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
64% less capital invested
Capital invested by funds: $9.31M → $3.37M (-$5.93M)
Holders
47
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$98.1K | |
| 2 | +$19.2K | |
| 3 | +$8.91K | |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$5.47K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.03K |
Top Sellers
| 1 | -$119K | |
| 2 | -$33K | |
| 3 | -$28.2K | |
| 4 |
SCA
STALEY CAPITAL ADVISERS
Pittsburgh,
Pennsylvania
|
-$26K |
| 5 |
GRP
Global Retirement Partners
San Rafael,
California
|
-$18K |